Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective of this trial is to evaluate the safety and tolerability of extended treatment with depsipeptide in patients who have at least demonstrated stable disease on a prior Gloucester-sponsored depsipeptide clinical trial, and in the opinion of their physician/investigator might benefit from continued treatment with depsipeptide.
Inclusion criteria
- Refractory Prostate cancer